2022
DOI: 10.3389/ijph.2022.1604793
|View full text |Cite
|
Sign up to set email alerts
|

The Real-World Impact of Vaccination on COVID-19 Cases During Europe’s Fourth Wave

Abstract: Objectives: Disease control is important to limit the social, economic and health effects of COVID-19 and reduce the risk of novel variants emerging. Evidence suggests vaccines are less effective against the Omicron variant, but their impact on disease control is unclear.Methods: We used a longitudinal fixed effects Poisson regression model to assess the impact of vaccination on COVID-19 case rates across 32 countries in Europe from 13th October to 01st January 2022. We controlled for country and time fixed ef… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…The research related to the three months of March, April, and May 2020, which covered most of the period of the first wave of the pandemic in Europe (according to epidemiologists the first wave came to an end at the end of June 2020 [ 32 ]), and to November 2021. The latter was chosen for follow-up research because cases had been rising again in European countries, with the fourth wave having started in mid-October 2021 [ 34 ], and we were interested in learning if in that restrained pandemic situation notifications of medicine shortages might reach similar dimensions as the ones experienced approximately one and a half years earlier or if vulnerabilities in the supply chain would be mitigated.…”
Section: Methodsmentioning
confidence: 99%
“…The research related to the three months of March, April, and May 2020, which covered most of the period of the first wave of the pandemic in Europe (according to epidemiologists the first wave came to an end at the end of June 2020 [ 32 ]), and to November 2021. The latter was chosen for follow-up research because cases had been rising again in European countries, with the fourth wave having started in mid-October 2021 [ 34 ], and we were interested in learning if in that restrained pandemic situation notifications of medicine shortages might reach similar dimensions as the ones experienced approximately one and a half years earlier or if vulnerabilities in the supply chain would be mitigated.…”
Section: Methodsmentioning
confidence: 99%